Merck tops quarterly estimates, posts modest 2026 guidance as generic competition looms

Thread starter U.S. News
Start date Feb 3, 2026

U.S. News

Guest

Feb 3, 2026

Merck posted a modest 2026 outlook that fell short of estimates, as it prepares for some drugs to go off patent later this year and face generic competition.

Continue reading...

You must log in or register to reply here.

Facebook X Bluesky LinkedIn Reddit Pinterest Tumblr WhatsApp Email Link

Thread Information

Title: Merck tops quarterly estimates, posts modest 2026 guidance as generic competition looms

Prefix: N/A

Forum: USA News

Start date: Feb 3, 2026

Last reply date: Feb 3, 2026

Replies: 0

Thread Tags

Thread statistics

Created: U.S. News, Feb 3, 2026

Replies: 0

Views: 1

About Us

XenTR Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book.

It is a long established fact that a reader will be distracted by the readable content of a page when looking at its layout.

Color picker

Search